Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brest, A. N.
Right arrow Articles by Moyer, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brest, A. N.
Right arrow Articles by Moyer, J. H.
(Chest. 1962;41:582-587.)
© 1962 American College of Chest Physicians

Antihypertensive Drug Therapy: Current Status

Albert N. Brest M.D.1 and John H. Moyer M.D., F.C.C.P.1

1 Hypertension-Renal Unit, Hahnemann Medical College and Hospital

At present, there are few patients whose blood pressure cannot be reduced to normotensive levels with the available hypotensive agents. Often a double or tripledrug regimen is required. The ultimate goal of the therapist will be accomplished, however, only when the underlying etiology of essential hypertension is discovered.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1962 by the American College of Chest Physicians.